GXY: Electrode, Cutaneous

Product code GXY, “Electrode, Cutaneous” in FDA's classification database, is a Class II device type under 21 CFR 882.1320 (cutaneous electrode), reviewed by FDA's Neurology panel. FDA's 510(k) database lists 440 clearances under GXY, 133 of them since 2011.
Updated Oct 29, 2026 · Clearances from FDA’s 510(k) database, as of Oct 29, 2026
Product code
GXY
Regulation
21 CFR 882.1320
Class
II
Panel
Neurology
Clearances
440
Most recent
Aug 27, 2026
Median review, last 2 years
144 days
Third-party review
Eligible
Implant
No

What it covers

A cutaneous electrode is an electrode that is applied directly to a patient's skin either to record physiological signals (e.g., the electroencephalogram) or to apply electrical stimulation.

The identification in 21 CFR 882.1320, cutaneous electrode. FDA gives GXY no definition of its own, so the regulation’s describes it.

Recent clearances

510(k)DeviceApplicantDecisionType
K262654Dexus Prosthetic System (MSL2, MSR2)Zhejiang Qiangnao Technology Co.,LtdAug 27, 2026Special
K260578Ambu® NeurolineTM Cup MRI/CT (Models 72704/21US, 72704/23US, 72704/25US, 72704/27US) Ambu® NeurolineTM Cup MRI/CT-set (Models 72704/21-1010US, 72704/21-1010US, 72704/23-1010US, 72704/25-1010US, 72704/27-1010US) Ambu® NeurolineTM Cup MRI/CT-mini set (Models 72704/21-0301US, 72704/23-0301US, 72704/25-0301US, 72704/27-0301US)Ambu A/SJul 14, 2026Traditional
K261442Charlotte ACC25 Surface Electrode Array; Charlotte ACC25 Reusable Surface Electrode ArrayCadwell Industries, Inc.Jun 26, 2026Abbreviated
K261522BioWave BioWrapsBiowave CorporationJun 3, 2026Special
K253237Elde Medical Electrodes (T5/ 5 cm x 5cm electrode T10/ 5 cm x 10cm electrode)Elde Medikal Sanayi ve Ticaret Anonim SirketiMay 8, 2026Traditional
K254183MR Conditional Cup ElectrodesTechnomed EuropeMay 7, 2026Traditional
K252439Tutamen Self Adhesive ElectrodesDongguan Tutamen Metalwork Co., Ltd.May 1, 2026Traditional
K253256myosmart. (13E522); myosmart.cuff (757M20-2); connectgrip. (560X27-1); myosmart trial kit (642V64=T)Otto Bock Healthcare Products GmbHApr 22, 2026Traditional
K260363Ceribell Brain Monitor HeadbandCeribell, Inc.Apr 3, 2026Abbreviated
K260453Remote Wave Electrode (AE03-50); Remote Wave Electrode (AE03-60)Bionit Labs SrlMar 12, 2026Special
From FDA’s 510(k) database, as of Oct 29, 2026Export CSV (100 rows free · all 440 with a free account)

Clearances by year

133 GXY 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.

YearClearancesMedian days to decision
2026 (so far)1158
20256148
20247111
202313132
2022581
202112195
20204108
20199113
201814135
20179116
20166170
20156119
20149203
2013799
20129150
20116183

Who submits

99 applicants cleared a GXY device since 2011. 44% of the clearances went to applicants in United States, then China (32%), South Korea (5%) and Taiwan (4%). By type: Traditional 85%, Abbreviated 8% and Special 8%. 5 went through a third-party review organization.

ApplicantClearances since 2011
Ceribell, Inc.7
Guangzhou Xinbo Electronic Co., Ltd.5
Rhythmlink International, LLC4
Bio Protech, Inc.3
Coapt, LLC3
Infinite Biomedical Technologies, LLC3
Axelgaard Mfg. Co., Ltd.2
Bio-Medical Research, Ltd.2

How FDA classifies it

Class II (performance standards).

From 21 CFR 882.1320.

Standards

21 CFR 882.1320 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent GXY clearances declared.

Ask about GXY

US FDA devices: 510(k), De Novo, guidance, 21 CFR

Questions about GXY

What is FDA product code GXY?

Product code GXY, “Electrode, Cutaneous” in FDA's classification database, is a Class II device type under 21 CFR 882.1320 (cutaneous electrode), reviewed by FDA's Neurology panel. FDA's 510(k) database lists 440 clearances under GXY, 133 of them since 2011.

How many 510(k) clearances are there under GXY?

FDA’s 510(k) database listed 440 clearances under GXY as of Oct 29, 2026, 133 of them decided since 2011; the most recent decision was Aug 27, 2026. The Predicate Finder searches the live database.

How long does FDA take to clear a GXY 510(k)?

For the 19 GXY clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 144 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.

Which companies have the most GXY clearances?

Since 2011: Ceribell, Inc. (7), Guangzhou Xinbo Electronic Co., Ltd. (5), Rhythmlink International, LLC (4), Bio Protech, Inc. (3) and Coapt, LLC (3). 99 applicants have cleared a GXY device in that time.

Sources

  1. FDA product classification: GXY · Product Classification database
  2. 21 CFR 882.1320: Cutaneous electrode · eCFR, as of Oct 27, 2026
  3. openFDA 510(k) query for GXY · run Oct 29, 2026
  4. 510(k) Premarket Notification database · FDA, accessdata.fda.gov
Follow GXYGet an email when FDA clears, recalls or publishes guidance for GXY devices.

Know what FDA already cleared.